home / stock / nby / nby news


NBY News and Press, NovaBay Pharmaceuticals Inc. From 11/12/21

Stock Information

Company Name: NovaBay Pharmaceuticals Inc.
Stock Symbol: NBY
Market: NYSE
Website: novabay.com

Menu

NBY NBY Quote NBY Short NBY News NBY Articles NBY Message Board
Get NBY Alerts

News, Short Squeeze, Breakout and More Instantly...

NBY - NovaBay Pharmaceuticals' (NBY) CEO Justin Hall on Q3 2021 Results - Earnings Call Transcript

NovaBay Pharmaceuticals, Inc. (NBY) Q3 2021 Earnings Conference Call November 11, 2021 4:30 PM ET Company Participants Jody Cain – Investor Relations, LHA Justin Hall – Chief Executive Officer and General Counsel Andy Jones – Chief Financial Officer Audrey Kunin – ...

NBY - NovaBay EPS misses by $0.01, misses on revenue

NovaBay (NYSE:NBY): Q3 GAAP EPS of -$0.05 misses by $0.01. Revenue of $1.84M (-15.2% Y/Y) misses by $0.6M. Press Release For further details see: NovaBay EPS misses by $0.01, misses on revenue

NBY - NovaBay Pharmaceuticals Reports Third Quarter 2021 Financial Results

DERMAdoctor acquisition significantly expands NovaBay’s presence in the large and lucrative skincare market DERMAdoctor transaction is immediately accretive to NovaBay’s earnings with expected profitability within one year Conference call begins at 4:30 p...

NBY - NovaBay Pharmaceuticals Closes DERMAdoctor Acquisition

Company to hold third quarter 2021 earnings call on November 11 and will discuss plans for the combined companies NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces the closing of the previously announced acquisition of DERMAdoctor, LLC. The Company ...

NBY - NovaBay Pharmaceuticals Closes $15.0 Million Private Placement

Private Placement allows Company to close on DERMAdoctor acquisition this week NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces the closing of a previously announced private placement for gross p...

NBY - NovaBay Pharmaceuticals Announces Pricing of $15.0 Million Private Placement

Private Placement to fund acquisition of DERMAdoctor NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces it has entered into a Securities Purchase Agreement with certain institutional investors in c...

NBY - NovaBay Pharmaceuticals, Inc. (NBY) CEO Justin Hall on DERMAdoctor Acquisition - Conference Call Transcript

NovaBay Pharmaceuticals, Inc. (NBY) DERMAdoctor Acquisition Conference Call September 29, 2021, 04:30 PM ET Company Participants Jody Cain - SVP, LHA, IR Justin Hall - CEO Audrey Kunin - DERMAdoctor, Co-Founder and Chief Product Officer Jeffrey Kunin - DERMAdoctor President, CEO and Co-Founde...

NBY - NovaBay DERMAdoctor Transaction Call

The following slide deck was published by NovaBay Pharmaceuticals, Inc. in conjunction with this event. For further details see: NovaBay DERMAdoctor Transaction Call

NBY - NovaBay Pharmaceuticals to Hold Conference Call and Webcast With Slide Presentation Today to Discuss Acquisition of DERMAdoctor

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces that management will discuss its acquisition of DERMAdoctor on an investment community conference call and webcast with accompanying slide presentation today, Wednesday, September 29, 2021 beginning at 4:30 p.m....

NBY - Why These Penny Stocks Deserve a Spot On Your Watchlist Right Now

3 Penny Stocks to Add to Your Watchlist in October 2021 Right now, there is major movement among both penny stocks and blue chips. And, with so many catalysts contributing to the volatility in the stock market, how can we as investors stay ahead? Well, the best way to do so is to stay a...

Previous 10 Next 10